# Abbott Laboratories revenue entity: /record/abbott-laboratories.md predicate: revenue page: /record/abbott-laboratories/revenue as_of: 2026-11-09 cite: AsOf. "Abbott Laboratories quarterly revenue: 13,013,000,000 United States dollar", as of 2026-09-30. Claim clm_080974839279, https://asof.is/claim/clm_080974839279, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/0001628280-26-070154-index.htm. As of November 9, 2026, the latest revenue figure on the AsOf record for Abbott Laboratories is $13.01 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Abbott Laboratories's latest full-year revenue is $44.33 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 19 claims on Abbott Laboratories's revenue, 1 open and 18 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest revenue The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_revenue claim, kept apart from the full-year series. Every quarterly revenue figure: /record/abbott-laboratories/quarterly_revenue.md - [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_revenue | 13,013,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_080974839279](/claim/clm_080974839279.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828026070154/0001628280-26-070154-index.htm ## Latest full-year revenue What the record asserts on 2026-11-09. - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 44,328,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7C1D7352CFA6](/claim/clm_7C1D7352CFA6.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 25,914,238,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_F17A9DA7A446](/claim/clm_F17A9DA7A446.md) | [clm_1AE9E329ED59](/claim/clm_1AE9E329ED59.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746910001018/0001047469-10-001018-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 29,527,552,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_BF21BA903CA4](/claim/clm_BF21BA903CA4.md) | [clm_F17A9DA7A446](/claim/clm_F17A9DA7A446.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746910001018/0001047469-10-001018-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 30,764,707,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_FBAB25A659DE](/claim/clm_FBAB25A659DE.md) | [clm_BF21BA903CA4](/claim/clm_BF21BA903CA4.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746910001018/0001047469-10-001018-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 35,166,721,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_80F33B0D967B](/claim/clm_80F33B0D967B.md) | [clm_FBAB25A659DE](/claim/clm_FBAB25A659DE.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746911001056/0001047469-11-001056-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 38,851,259,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_B4C1932FF6FA](/claim/clm_B4C1932FF6FA.md) | [clm_80F33B0D967B](/claim/clm_80F33B0D967B.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746912001216/0001047469-12-001216-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 39,873,910,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_9516B11C6785](/claim/clm_9516B11C6785.md) | [clm_B4C1932FF6FA](/claim/clm_B4C1932FF6FA.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746913001180/0001047469-13-001180-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 21,848,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_0D3539091ADB](/claim/clm_0D3539091ADB.md) | [clm_9516B11C6785](/claim/clm_9516B11C6785.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746914001176/0001047469-14-001176-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 20,247,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_16E555E53E25](/claim/clm_16E555E53E25.md) | [clm_0D3539091ADB](/claim/clm_0D3539091ADB.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746915001377/0001047469-15-001377-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 20,405,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_305771785CD8](/claim/clm_305771785CD8.md) | [clm_16E555E53E25](/claim/clm_16E555E53E25.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746916010246/0001047469-16-010246-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 20,853,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_CBCFC23B00BC](/claim/clm_CBCFC23B00BC.md) | [clm_305771785CD8](/claim/clm_305771785CD8.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/0001047469-19-000624-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 27,390,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_B704D1D4A319](/claim/clm_B704D1D4A319.md) | [clm_CBCFC23B00BC](/claim/clm_CBCFC23B00BC.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/0001047469-19-000624-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 30,578,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_1395DECF0604](/claim/clm_1395DECF0604.md) | [clm_B704D1D4A319](/claim/clm_B704D1D4A319.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000104746919000624/0001047469-19-000624-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 31,904,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_C6D9CE4452DC](/claim/clm_C6D9CE4452DC.md) | [clm_1395DECF0604](/claim/clm_1395DECF0604.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000110465920023904/0001104659-20-023904-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 34,608,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_DA5BB69D989B](/claim/clm_DA5BB69D989B.md) | [clm_C6D9CE4452DC](/claim/clm_C6D9CE4452DC.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000110465921025751/0001104659-21-025751-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 43,075,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_6FD3450A3DD5](/claim/clm_6FD3450A3DD5.md) | [clm_DA5BB69D989B](/claim/clm_DA5BB69D989B.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000110465922025141/0001104659-22-025141-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 43,653,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_8BADD4D79F8F](/claim/clm_8BADD4D79F8F.md) | [clm_6FD3450A3DD5](/claim/clm_6FD3450A3DD5.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 40,109,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_AC0EC8434FB1](/claim/clm_AC0EC8434FB1.md) | [clm_8BADD4D79F8F](/claim/clm_8BADD4D79F8F.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 41,950,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_7C1D7352CFA6](/claim/clm_7C1D7352CFA6.md) | [clm_AC0EC8434FB1](/claim/clm_AC0EC8434FB1.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm - [Abbott Laboratories](/record/abbott-laboratories.md) | revenue | 44,328,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7C1D7352CFA6](/claim/clm_7C1D7352CFA6.md) sources: https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm ## What replaced what - $25.91 billion (2007-12-31 to 2008-12-31, [clm_1AE9E329ED59](/claim/clm_1AE9E329ED59.md)) was replaced by $29.53 billion from 2008-12-31 ([clm_F17A9DA7A446](/claim/clm_F17A9DA7A446.md)) - $29.53 billion (2008-12-31 to 2009-12-31, [clm_F17A9DA7A446](/claim/clm_F17A9DA7A446.md)) was replaced by $30.76 billion from 2009-12-31 ([clm_BF21BA903CA4](/claim/clm_BF21BA903CA4.md)) - $30.76 billion (2009-12-31 to 2010-12-31, [clm_BF21BA903CA4](/claim/clm_BF21BA903CA4.md)) was replaced by $35.17 billion from 2010-12-31 ([clm_FBAB25A659DE](/claim/clm_FBAB25A659DE.md)) - $35.17 billion (2010-12-31 to 2011-12-31, [clm_FBAB25A659DE](/claim/clm_FBAB25A659DE.md)) was replaced by $38.85 billion from 2011-12-31 ([clm_80F33B0D967B](/claim/clm_80F33B0D967B.md)) - $38.85 billion (2011-12-31 to 2012-12-31, [clm_80F33B0D967B](/claim/clm_80F33B0D967B.md)) was replaced by $39.87 billion from 2012-12-31 ([clm_B4C1932FF6FA](/claim/clm_B4C1932FF6FA.md)) - $39.87 billion (2012-12-31 to 2013-12-31, [clm_B4C1932FF6FA](/claim/clm_B4C1932FF6FA.md)) was replaced by $21.85 billion from 2013-12-31 ([clm_9516B11C6785](/claim/clm_9516B11C6785.md)) - $21.85 billion (2013-12-31 to 2014-12-31, [clm_9516B11C6785](/claim/clm_9516B11C6785.md)) was replaced by $20.25 billion from 2014-12-31 ([clm_0D3539091ADB](/claim/clm_0D3539091ADB.md)) - $20.25 billion (2014-12-31 to 2015-12-31, [clm_0D3539091ADB](/claim/clm_0D3539091ADB.md)) was replaced by $20.41 billion from 2015-12-31 ([clm_16E555E53E25](/claim/clm_16E555E53E25.md)) - $20.41 billion (2015-12-31 to 2016-12-31, [clm_16E555E53E25](/claim/clm_16E555E53E25.md)) was replaced by $20.85 billion from 2016-12-31 ([clm_305771785CD8](/claim/clm_305771785CD8.md)) - $20.85 billion (2016-12-31 to 2017-12-31, [clm_305771785CD8](/claim/clm_305771785CD8.md)) was replaced by $27.39 billion from 2017-12-31 ([clm_CBCFC23B00BC](/claim/clm_CBCFC23B00BC.md)) - $27.39 billion (2017-12-31 to 2018-12-31, [clm_CBCFC23B00BC](/claim/clm_CBCFC23B00BC.md)) was replaced by $30.58 billion from 2018-12-31 ([clm_B704D1D4A319](/claim/clm_B704D1D4A319.md)) - $30.58 billion (2018-12-31 to 2019-12-31, [clm_B704D1D4A319](/claim/clm_B704D1D4A319.md)) was replaced by $31.9 billion from 2019-12-31 ([clm_1395DECF0604](/claim/clm_1395DECF0604.md)) - $31.9 billion (2019-12-31 to 2020-12-31, [clm_1395DECF0604](/claim/clm_1395DECF0604.md)) was replaced by $34.61 billion from 2020-12-31 ([clm_C6D9CE4452DC](/claim/clm_C6D9CE4452DC.md)) - $34.61 billion (2020-12-31 to 2021-12-31, [clm_C6D9CE4452DC](/claim/clm_C6D9CE4452DC.md)) was replaced by $43.08 billion from 2021-12-31 ([clm_DA5BB69D989B](/claim/clm_DA5BB69D989B.md)) - $43.08 billion (2021-12-31 to 2022-12-31, [clm_DA5BB69D989B](/claim/clm_DA5BB69D989B.md)) was replaced by $43.65 billion from 2022-12-31 ([clm_6FD3450A3DD5](/claim/clm_6FD3450A3DD5.md)) - $43.65 billion (2022-12-31 to 2023-12-31, [clm_6FD3450A3DD5](/claim/clm_6FD3450A3DD5.md)) was replaced by $40.11 billion from 2023-12-31 ([clm_8BADD4D79F8F](/claim/clm_8BADD4D79F8F.md)) - $40.11 billion (2023-12-31 to 2024-12-31, [clm_8BADD4D79F8F](/claim/clm_8BADD4D79F8F.md)) was replaced by $41.95 billion from 2024-12-31 ([clm_AC0EC8434FB1](/claim/clm_AC0EC8434FB1.md)) - $41.95 billion (2024-12-31 to 2025-12-31, [clm_AC0EC8434FB1](/claim/clm_AC0EC8434FB1.md)) was replaced by $44.33 billion from 2025-12-31 ([clm_7C1D7352CFA6](/claim/clm_7C1D7352CFA6.md)) ## Questions this record answers ### What is Abbott Laboratories's current revenue? The latest figure on the record is $13.01 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $44.33 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was Abbott Laboratories's revenue for the quarter ended September 30, 2026? $13.01 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Abbott Laboratories's revenue last change? The latest value on the record is $44.33 billion, dated December 31, 2025; before it the record holds $41.95 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Abbott Laboratories's revenue before $44.33 billion? $41.95 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/abbott-laboratories/revenue (markdown: /record/abbott-laboratories/revenue.md) - Entity twin: /record/abbott-laboratories.md ยท timeline: /timelines/abbott-laboratories.md - Every company's revenue: /facts/revenue.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.